Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
10/2009
10/29/2009US20090269324 Antimicrobial peracid compositions with selected catalase enzymes and methods of use in aseptic packaging
10/29/2009US20090269305 Novel macrocyclic inhibitors of hepatitis c virus replication
10/29/2009US20090269298 Agent for the prevention and treatment of sexually transmitted diseases-i
10/29/2009DE102008020387A1 Use of pharmaceutical formulation comprising matrix e.g. polysaccharides cellulose and dextran, with protein adsorptive properties, for the prevention or alleviation of symptoms by volatile body sensitizer, infectious or toxic impurities
10/29/2009CA2722445A1 Nanoemulsions for treating fungal, yeast and mold infections
10/29/2009CA2722404A1 Methods of treating fungal infections
10/29/2009CA2722306A1 Treatment of hepatitis c virus infections with telaprevir (vx-950) in patients non-responsive to treatment with pegylated interferon-alpha-2a/2b and ribavirin
10/29/2009CA2722240A1 Tat protein for preventing or treating aids
10/29/2009CA2722177A1 1'-substituted carba-nucleoside analogs for antiviral treatment
10/29/2009CA2722084A1 Carba-nucleoside analogs for antiviral treatment
10/29/2009CA2722075A1 Long-chain fatty acyl elongase inhibitor comprising arylsulfonyl derivative as active ingredient
10/29/2009CA2721944A1 Pyrrole antifungal agents
10/29/2009CA2721919A1 Limk2 inhibitors, compositions comprising them, and methods of their use
10/29/2009CA2721870A1 Genetically modified human umbilical cord perivascular cells for prophylaxis against or treatment of biological or chemical agents
10/29/2009CA2720677A1 Compositions and methods to enhance the immune system
10/29/2009CA2720465A1 Methods and compounds for mitigating pathogenic outbreaks using replikin count cycles
10/28/2009EP2112228A1 Method for detecting pathogenic microorganism and antimicrobial agent, method for evaluating effect of antimicrobial agent, and antimicrobial agent
10/28/2009EP2112220A2 Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences
10/28/2009EP2112157A1 Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses
10/28/2009EP2112154A1 Esters in position 20 of camptothecins
10/28/2009EP2111869A1 Compositions and methods to enhance the immune system
10/28/2009EP2111396A1 Hcv inhibiting macrocyclic phenylcarbamates
10/28/2009EP2111232A1 A novel medicinal formulation for inducing an immune response in patients with chronic and recurring infections
10/28/2009EP1786779B1 4-arylazo-3,5-diamino-pyrazole compounds and use thereof
10/28/2009EP1758469B1 Improvement of barrier integrity in hiv patients by use of fatty acids
10/28/2009EP1745052B9 Hiv integrase inhibitors: cyclic pyrimidinone compounds
10/28/2009EP1503800B1 Treatment and prevention of tissue damage associated with increased c-reactive protein production
10/28/2009EP1497438B1 Means and methods for the production of adenovirus vectors
10/28/2009EP1474120B1 Antibody having a t-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease
10/28/2009EP1404323B1 Use of methylnaltrexone to treat immune suppression
10/28/2009EP1379504B1 Bipiperidinyl-derivatives and their use as chemokine receptors inhibitors
10/28/2009EP1181047B2 Composition comprising alkaline sphingomyelinase of bacterial origin for use as a dietetic preparation, food supplement or pharmaceutical product
10/28/2009EP1150666B1 Gm-csf for the treatment of crohn's disease
10/28/2009EP1098908B1 Anti-ccr2 antibodies and methods of use therefor
10/28/2009EP1071758B1 Porcine adenovirus vector
10/28/2009EP0983361B1 Bacterial pheromones and uses therefor
10/28/2009CN101568543A Macrocyclic peptides as hepatitis c virus inhibitors
10/28/2009CN101568538A Thiophene analogues for the treatment or prevention of flavivirus infections
10/28/2009CN101568336A Macrocyclic peptides as hepatitis C virus inhibitors
10/28/2009CN101568257A Antibacterial agent and bactericidal agent
10/28/2009CN101565703A Eriocheir sinensis Crustin-2 gene and application of recombinant protein thereof
10/28/2009CN101565462A Large yellow croaker BPI-BN protein, primer and applications thereof in preparing antibiotic drugs
10/28/2009CN101565459A Streptococcus pneumoniae proteins and nucleic acid molecules
10/28/2009CN101565458A Peptide vaccine for animal and preparation method thereof
10/28/2009CN101565457A Synthetic peptide vaccine and preparation method thereof
10/28/2009CN101565455A CTL epitope polypeptides of bird flu H5N1 virus and applications thereof
10/28/2009CN101565428A Preparation method of prulifloxacin
10/28/2009CN101565427A Preparation method of cefdinir
10/28/2009CN101565426A Aspoxicillin-ethanol adduct crystalline and preparation method thereof
10/28/2009CN101565425A 6H-thiochromene [3, 4-e] [1, 2, 4] triazole [1, 5-a] pyrimidine compound with anti-inflammatory and anti-fungal activity
10/28/2009CN101565424A 6H-thiochromene [4, 3-d][1, 2, 4] triazole [1, 5-a] pyrimidine class compound with anti-inflammatory and antifungal activities
10/28/2009CN101565412A Sulphonamide derivatives as prodrugs of aspartyl protease inhibitors
10/28/2009CN101565398A Process for preparing atazanavir bisulfate and novel forms
10/28/2009CN101565359A Process for the preparation of entecavir and novel intermediates thereof via carbon-silicon oxidation
10/28/2009CN101564538A 3, 5-dihydroxy-4-isopropyl diphenyl ethylene-butanedioic anhydride-polyoxyethylene compound and synthetic method thereof
10/28/2009CN101564537A 3, 5-dihydroxy-4-isopropyl diphenyl ethylene-ethyl bromoacetate-polyoxyethylene compound and synthetic method thereof
10/28/2009CN101564533A Hepatitis E protein-nucleic acid composite vaccine and preparation method thereof
10/28/2009CN101564524A Traditional Chinese medicine injection for treating canine parvovirus disease and preparation method thereof
10/28/2009CN101564519A External medicine for treating parasitic infection, fungal infection and bacterial infection of pets and preparation method thereof
10/28/2009CN101564510A Chinese medicament liniment for effectively treating fungal infection of hand
10/28/2009CN101564509A Medicament for treating early encephalitis B
10/28/2009CN101564508A Medicinal tea for preventing encephalitis and preparation method thereof
10/28/2009CN101564507A Medicament for preventing encephalitis
10/28/2009CN101564498A External traditional Chinese medicine composition for curing mumps
10/28/2009CN101564497A Medicament for treating acquired immune deficiency syndrome
10/28/2009CN101564480A Medicine for preventing fowl plague
10/28/2009CN101564479A Traditional Chinese medicine for curing avian influenza and newcastle disease
10/28/2009CN101564475A Application of Kegan Liyan Oral Liquid in preparing Chinese medicaments for preventing and treating bird flu
10/28/2009CN101564471A Preparation method of buccal tablets for treating laryngeal disease
10/28/2009CN101564459A Application of Chinese medicinal composition in preparing medicament for treating upper respiratory tract infection
10/28/2009CN101564451A Traditional Chinese medicine for curing chicken white diarrhea
10/28/2009CN101564429A Fowl Chinese medicine granular formulation for preventing infectious bursal disease and preparation method thereof
10/28/2009CN101564426A Medicament for external use for treating onychomycosis
10/28/2009CN101564412A Traditional Chinese medicine composition for preventing fowl pox and preparation method thereof
10/28/2009CN101564408A Medicinal composition containing korean ginseng for make hiv-1 have 5ltr/gag genetic defect
10/28/2009CN101564400A Antibacterial supermolecule aquogel and preparation method and application thereof
10/28/2009CN101564397A Difluprednate and tobramycin containing composition for eyes or ears and nose and application thereof
10/28/2009CN101564395A Ophthalmic or otic and nasal composition containing difluprednate and lavo-ofloxacin and application thereof
10/28/2009CN101564389A Application of arbidol hydrochloride in preparing medicine for preventing and treating canine distemper virus
10/28/2009CN101564386A Novel applications of pinane amine as M2 inhibitor in pharmacy
10/28/2009CN101564385A Application of aether in preparing anti-AIDS medicaments
10/28/2009CN100554966C A screening method
10/28/2009CN100554428C Nucleic acid sequence for potentiating the expression of useful gene and method therefor
10/28/2009CN100554270C Method for preparing dehydrogenated cavidine, dehydrogenated apocavidine and combination
10/28/2009CN100554255C Benzoisoselenothiazolidone derivatives and their preparing process and use
10/28/2009CN100554245C Processes for the preparation of 4- 4- 4-(2 -cyanoethenyl)-2,6-dimethylphenyl )amino) -2-pyrimidinyl)amino benzonitrile
10/28/2009CN100553672C Freeze-dried powder injection for injection for brain refreshment and its preparing method
10/28/2009CN100553647C Method for preparing extractive of purple daisy
10/28/2009CN100553636C Method of using diketopiperazines and composition containing them
10/27/2009US7608726 Substituted indolepyridinium as anti-infective compounds
10/27/2009US7608718 4,5-dihydro-1H-pyrazole derivatives having potent CB1-antagonistic activity
10/27/2009US7608691 Antibodies against IL-16 antagonist peptides
10/27/2009US7608683 Human leukocyte antigen pan DR-binding peptides for use in the treatment of infections, inflammatory, autoimmune and cancer diseases; has heat shock protein that is capable of binding to MHC class II molecules
10/27/2009US7608638 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
10/27/2009US7608632 Sulfonamide inhibitors of aspartyl protease
10/27/2009US7608601 4′-Substituted nucleoside derivatives as inhibitors of HCV RNA replication
10/27/2009US7608597 For therapy and prophylaxis of a Hepatitis C virus infection in a host
10/27/2009US7608596 10-substituted macrolide antibiotics
10/27/2009US7608452 Polynucleotides encoding cytokine receptor zcytor19
10/27/2009US7608422 Gene therapy; vaccines; inducing antibodies and/or cytotoxic or helper T lymphocytes
1 ... 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 ... 1798